ASCLS eNewsBytes
May. 8, 2012

Clinical lab industry should prepare for many marketplace changes
Dark Daily
It was a big opening for the 17th annual Executive War College on Laboratory and Pathology Management on May 2. A record crowd of about 700 enthusiastic clinical laboratory managers and pathologists heard lab industry leaders predict a fast-changing future for the medical laboratory testing industry.More

Provista Diagnostics, Inc. opens new analytical laboratory facility
Market Watch
Provista Diagnostics, Inc., a provider of oncology-based diagnostic tests and clinical laboratory services to the pharmaceutical and biotechnology industries, is pleased to announce the opening of its new 13,611 square foot laboratory. The newly remodeled facility, located in Scottsdale, Ariz., will house the Provista Dx Reference Laboratory, an innovative, leading-edge CLIA accredited laboratory that is also GLP compliant.More

'Doomsday' flu virus replicated in lab
The Calgary Herald
One of the most controversial genetically altered microbes ever created was unveiled last week — complete with instructions on how to engineer the hybrid flu virus in the lab. The details, published in the journal Nature, have been under wraps for months because of fears they might be misused by bioterrorists.More

New technique uses electrons to map nanoparticle atomic structures
Lab Manager Magazine
With dimensions measuring billionths of a meter, nanoparticles are way too small to see with the naked eye. Yet it is becoming possible for today's scientists not only to see them, but also to look inside at how the atoms are arranged in three dimensions using a technique called nanocrystallography. More

California lab reviewing protocols after death of researcher who handled deadly bacteria strain
The Washington Post
Lab workers at the San Francisco Veterans Affairs medical center will be urged to get vaccinations for the diseases they study as a precaution as investigators continue looking into a researcher's death after he handled a rare strain of bacteria, officials said recently.More

FDA staff question Pfizer arthritis drug benefits
U.S. drug reviewers on May 7 questioned whether the benefits of Pfizer Inc.'s experimental treatment for rheumatoid arthritis outweighed its risks of cancerous cells and infections. The Food and Drug Administration staff said the drug, called tofacitinib, appeared to reduce swollen and tender joints during clinical trials. But the staff questioned the method of analyzing X-rays to prove the drug worked.More

How to talk to patients about genetic testing
American Medical News
What is the primary care doctor's role in direct-to-consumer genetic testing? Your patient, Ms. X, says she is planning to order a comprehensive genetic profile on herself from a commercial laboratory (such as 23andMe or MapMyGene). She asks for your opinion, since someone told her to check with her physician before going ahead.More

British scientists growing 'human spare parts' in laboratory
IBN Live
British scientists claim to be for the first time growing human body parts at a laboratory at the University College London, which they say could soon make organ donation a thing of the past. A team, led by Alexander Seifalian of the varsity's Department of Nanotechnology and Regenerative Medicine, claims it's actually focusing on growing replacement organs and body parts to order, using a patient's own cells. More

American Society for Clinical Pathology and the American Society of Cytopathology sign a memorandum of understanding
Digital Journal
The American Society for Clinical Pathology and the American Society of Cytopathology have signed a Memorandum of Understanding to partner on education, scientific discovery, and advocacy initiatives that will mutually benefit the pathologists, cytopathologists, laboratory professionals and cytotechnologists who belong to the societies.More

Study shows birth defects more common with single sperm injection over IVF
Metro News
Test-tube babies have higher rates of birth defects, and doctors have long wondered: Is it because of certain fertility treatments or infertility itself? A large new study from Australia suggests both may play a role. Compared to those conceived naturally, babies that resulted from simple IVF, or in vitro fertilization — mixing eggs and sperm in a lab dish — had no greater risk of birth defects once factors such as the mom's age and smoking were taken into account.More

FDA to review drug intended for HIV prevention
The Philadelphia Inquirer
Preventing HIV/AIDS has been a goal since the disease was recognized in the 1980s. This week, for the first time, a U.S. Food and Drug Administration advisory committee will review a new drug application for a compound that its manufacturer says will help prevent AIDS.More

Health research as a cure for economy?
The Columbus Dispatch
Ohio's health-care sector increasingly sees medical research as a way to help heal not only patients but the state's economy. To that end, economic-development officials and researchers say deriving more tangible results from the hundreds of millions of health-research dollars that flow through the state's academic centers and hospitals is essential.More